Genocea Biosciences (NASDAQ:GNCA) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research report sent to investors on Monday morning. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Price Performance Genocea Biosciences has a 12-month low of $0.00 and a 12-month high of $0.00. The company has a […]
StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research report sent to investors on Monday morning. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Price Performance Genocea Biosciences has a 12-month low of $0.00 and a 12-month high of $0.00. The company has a […]
